Patents by Inventor Kim Anthony Gonda

Kim Anthony Gonda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY
    Publication number: 20210206839
    Abstract: Chimeric antigen receptors (CARs) containing HIV envelope antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the CARs are also disclosed. Methods of treating or preventing HIV-infection in a subject, and methods of making CAR T cells are also disclosed. Results of treating or preventing HIV-infection, and results of making CAR T cells are also disclosed.
    Type: Application
    Filed: December 15, 2020
    Publication date: July 8, 2021
    Inventors: Kim Anthony Gonda, Dina Schneider, Rimas Orentas, Boro Dropulic
  • Compositions and methods for treating HIV/AIDS with immunotherapy
    Patent number: 10894819
    Abstract: Chimeric antigen receptors (CARs) containing HIV envelope antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the CARs are also disclosed. Methods of treating or preventing HIV-infection in a subject, and methods of making CAR T cells are also disclosed. Results of treating or preventing HIV-infection, and results of making CAR T cells are also disclosed.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: January 19, 2021
    Assignee: LENTIGEN TECHNOLOGY, INC.
    Inventors: Kim Anthony Gonda, Dina Schneider, Rimas Orentas, Boro Dropulic
  • COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY
    Publication number: 20190202895
    Abstract: Chimeric antigen receptors (CARs) containing HIV envelope antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the CARs are also disclosed. Methods of treating or preventing HIV-infection in a subject, and methods of making CAR T cells are also disclosed. Results of treating or preventing HIV-infection, and results of making CAR T cells are also disclosed.
    Type: Application
    Filed: December 20, 2018
    Publication date: July 4, 2019
    Inventors: Kim Anthony Gonda, Dina Schneider, Rimas Orentas, Boro Dropulic